Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
146,614,676
-
Number of holders
-
1018
-
Total 13F shares, excl. options
-
124,528,759
-
Shares change
-
+802,331
-
Total reported value, excl. options
-
$34,492,440,417
-
Value change
-
+$242,887,240
-
Put/Call ratio
-
1.2%
-
Number of buys
-
435
-
Number of sells
-
-447
-
Price
-
$276.92
Significant Holders of BIOGEN INC. - COM (BIIB) as of Q4 2022
1,190 filings reported holding BIIB - BIOGEN INC. - COM as of Q4 2022.
BIOGEN INC. - COM (BIIB) has 1,018 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 124,528,759 shares
of 146,614,676 outstanding shares and own 84.94% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (15,700,576 shares), BlackRock Inc. (14,260,613 shares), VANGUARD GROUP INC (11,976,623 shares), STATE STREET CORP (6,808,274 shares), WELLINGTON MANAGEMENT GROUP LLP (5,411,213 shares), GEODE CAPITAL MANAGEMENT, LLC (3,342,330 shares), JPMORGAN CHASE & CO (2,270,302 shares), DEUTSCHE BANK AG\ (1,851,114 shares), Clearbridge Investments, LLC (1,805,575 shares), and D. E. Shaw & Co., Inc. (1,756,082 shares).
This table shows the top 1018 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.